ArticleJournal of gastrointestinal oncology2025

Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis.

Yue Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.